Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea
NCT00455858
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
87
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
insulin detemir
Sponsor
Novo Nordisk A/S